Physician profile
Nathan T Morrell
NPI 1659508513
$38,638.37
in general payments reported to CMS, 2019-2025
11 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,250 · 2020: $32.89 · 2021: $2,069 · 2022: $7,570 · 2023: $7,604 · 2024: $5,988 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $3,050 · Food and Beverage: $2,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,156.25 |
| Travel and Lodging | $3,049.60 |
| Food and Beverage | $2,511.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $13,835.00 | 2022-2024 | Xiaflex |
| Acumed LLC | $13,244.36 | 2019-2025 | Acumed, Acumed, Inframe Implant |
| Smith+Nephew, INC. | $8,072.34 | 2019-2025 | Safeguard, Integra, Ascension |
| Endo USA, INC. | $1,668.08 | 2025 | Xiaflex |
| Anika Therapeutics, INC. | $1,259.15 | 2022 | |
| Skeletal Dynamics INC | $146.91 | 2025 | Geminus, Ijs, Implate |
| Djo, LLC | $138.95 | 2019 | |
| Kerecis Limited | $96.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Biocomposites INC | $86.10 | 2025 | Stimulan |
| Pacira Therapeutics, INC. | $49.94 | 2019 | |
| Stryker Corporation | $41.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Morrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.